Category: FSA

analysis, business, cannabis, cbd, compliance, consumer, cultivation, Epidiolex, EU, European, extraction, farm bill, FDA, Federal, FSA, government, growing, GW Pharma, industry, international, laboratories, laboratory, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, product, Quality, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, UK, union, United Kingdom

The CBD Regulatory Environment in Europe: Part 3

The CBD Regulatory Environment in Europe: Part 3

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part […]

analysis, analytics, Brexit, British, Briton, business, Business Analysis, california, CANADA, cannabidiol, cannabis, cbd, compliance, Concentrates & Extracts, consumer, cultivation, Dispensaries & Retail, dispensary, England, English, EU, europe, European, export, extraction, Federal, food, Food Standards Agency, FSA, government, growing, import, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, novel, novel food, product, Product Development, Quality, regulation, regulations, regulatory, retail, safety, standard, state, thc, UK, union, United Kingdom

The Changing Landscape of CBD in the UK

The Changing Landscape of CBD in the UK

Reports estimate that up to 8 million people in the UK use CBD for its variety of wellness benefits. The market is […]